Shilpa Medicare: Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. | Value Research

Best Funds for 2023: Handpicked Mutual Funds to build a winning portfolio.
(₹1,499 ₹999)

Buy Now Buy Now right-arrow

Shilpa Medicare: Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on November 19 2022 for Deepak Kumar Innani

Click here to view PDF


Other Categories